Company / Current Assets
Tyra Biosciences, Inc. Current Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$347.5M
FY2024
5-year range
$15.3M / $347.5M
FY2020-FY2024
Trend
+64.2%
vs FY2023
Sector context
#150 of 213
Health Care
What the data says
At $347M, Tyra Biosciences, Inc.'s current assets ranks #150 of 213 in the Health Care sector. Current Assets returned to growth in FY2024 after 2 years of decline, reaching $347M.
Based on SEC 10-K filings.
$347M in FY2024 with a 3-year CAGR of +4.5%.
Improved from $257M to $347M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#150 of 213 in Health CareTop 70% of 213This company $347.5M Sector average $2.5B
▼
-86.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +4.5%, indicating consistent growth.
- In FY2024, current assets increased 64.2% year-over-year.
- Ranks #150 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $347.5M | +64.2% |
| FY2023 | $211.7M | -17.7% |
| FY2022 | $257.3M | -15.4% |
| FY2021 | $304.1M | +1889.8% |
| FY2020 | $15.3M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026